GSDME, also known as DFNA5 (associated with autosomal dominant non-syndromic deafness), has recently been identified as a critical factor in caspase-3-mediated pyroptosis, particularly in chemotherapy-induced scenarios [8, 9]. This evidence concerns the gene GSDME and autosomal dominant nonsyndromic hearing loss.